Treatment of Patients Over 65 Years With Primary CNS Lymphoma: High-dose Methotrexate Combined With Chemo-immunotherapy Followed by Maintenance Therapy.

Trial Profile

Treatment of Patients Over 65 Years With Primary CNS Lymphoma: High-dose Methotrexate Combined With Chemo-immunotherapy Followed by Maintenance Therapy.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Jun 2017

At a glance

  • Drugs Lomustine (Primary) ; Methotrexate (Primary) ; Procarbazine (Primary) ; Rituximab (Primary) ; Dexamethasone; Folic acid
  • Indications Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Acronyms PRIMAIN
  • Most Recent Events

    • 15 Aug 2015 Status changed from active, no longer recruiting to completed as per European Clinical Trials Database record.
    • 11 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by German Clinical Trials Register record.
    • 19 Oct 2012 Planned number of patients changed from 56 to 112.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top